British scientists behind the trial believe it will ‘transform’ treatment Some 46,500 men are diagnosed with prostate cancer in the UK every year Research was unveiled at American Society for Clinical Oncology conference Thousands of men could benefit from a new way of treating prostate cancer that doubles their average life expectancy, research has found. Giving patients...
Post
Type 2 diabetes: New biopolymer injection may offer weeks of glucose control
Keeping blood glucose levels as close to normal as possible is important for people with type 2 diabetes, as it lowers the risk of serious complications. However, despite a long list of treatment options, patients still struggle with glucose control, especially when working out meal-specific doses. Treatments that cut down on injections are seen as...
Post
A compound in cannabis is ‘significantly’ effective in destroying cancerous tumours in leukaemia, study reveals
Cannabinoids had a ‘significant’ effect on the death of cancer cells in leukaemia Combination of the compounds and chemo had better results than chemo alone Results were greater when using cannabinoids after chemotherapy Cannabinoids are ‘a very exciting prospect in oncology,’ says study author However, Cancer Research UK warned cancer patients not to use cannabinoids...
Post
Gene-Based Therapy That Reprograms Immune Cells Offers Hope For Multiple Myeloma Cure
Multiple Myeloma The United States has more than 30,000 cases of multiple myeloma occurring each year. The condition affects the plasma cells that produce antibodies that fight infection. Between 60,000 and 70,000 American currently have the disease. Only about half of these patients are expected to live five years after their diagnosis. Now, a gene-based...
Post
Hope for thousands of women with ovarian cancer: Landmark trial shows new drug shrinks tumours in terminal stages of the illness
BTG945 drug significantly reduced tumours in seven out of 15 women Researchers will today unveil the preliminary findings at a Chicago conference Unlike most gruelling cancer therapies, there are very few side effects Thousands of women with ovarian cancer could be helped by the most promising new drug in a decade, British scientists claim. The...
Post
Prostate cancer treatment ‘could help more patients’
Image captionHormone therapy stops more testosterone from reaching the prostate gland One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional...
Post
Promising cancer treatment targets rare genetic flaw
An experimental cancer medicine called larotrectinib has shown promise treating a diverse range of cancers in people young and old, researchers said at a major cancer conference in the United States. The treatment targets a genetic abnormality which is often found in rare cancers—including salivary gland cancer, juvenile breast cancer, and a soft tissue cancer known as infantile fibrosarcoma—which are...
Post
An initial step toward blood tests for early detection of cancer
In a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumor DNA at a high rate. In 89 percent of patients, at least one genetic change detected in the tumor was also detected in the blood. Overall, 627 (73 percent) genetic changes found...
Post
Two Combination Therapies Shrink Melanoma Brain Metastases in More Than Half of Patients
CHICAGO – High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients who have been largely left out of recent treatment progress – those whose disease has spread to the brain. A combination regimen of two immunotherapies and another of two targeted therapies each...
Post
Scientists Light the Way for Immune System to Attack Cancer
The science behind harnessing the immune system to fight cancer is complicated, but a University of Rochester Medical Center laboratory discovered a simple, practical way to use light and optics to steer killer immune cells toward tumors. In a study published by the online journal Nature Communications, lead author Minsoo Kim, Ph.D., a UR professor of Microbiology and Immunology and a Wilmot Cancer...